Martingale Asset Management’s Verve Therapeutics VERV Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $565K | Sell |
50,350
-69
| -0.1% | -$775 | 0.01% | 596 |
|
|
2025
Q1 | $230K | Sell |
50,419
-3
| -0% | -$14 | 0.01% | 719 |
|
|
2024
Q4 | $284K | Sell |
50,422
-15
| -0% | -$85 | 0.01% | 697 |
|
|
2024
Q3 | $244K | Hold |
50,437
| – | – | 0.01% | 740 |
|
|
2024
Q2 | $246K | Buy |
50,437
+21,430
| +74% | +$105K | 0.01% | 724 |
|
|
2024
Q1 | $385K | Buy |
29,007
+805
| +3% | +$10.7K | 0.01% | 663 |
|
|
2023
Q4 | $393K | Buy |
28,202
+7,785
| +38% | +$109K | 0.01% | 655 |
|
|
2023
Q3 | $271K | Buy |
+20,417
| New | +$271K | 0.01% | 704 |
|
|
2023
Q2 | – | Sell |
-16,273
| Closed | -$235K | – | 879 |
|
|
2023
Q1 | $235K | Hold |
16,273
| – | – | ﹤0.01% | 748 |
|
|
2022
Q4 | $315K | Hold |
16,273
| – | – | 0.01% | 715 |
|
|
2022
Q3 | $559K | Buy |
+16,273
| New | +$559K | 0.01% | 597 |
|